Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Biotin supplements for hair improvement are popular without scientific proof of effectiveness.

Bimatoprost ophthalmic solution 0.03% safely and effectively increases eyelash growth when applied to the upper eyelid.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

COVID-19 may trigger sudden temporary hair loss.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Dermal papilla cells can help regrow hair and are promising for hair loss treatments.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.